Leadless Pacemakers: A 2025 Clinical & Market Overview

Leadless Pacemakers: A 2025 Clinical Snapshot

Leadless pacemakers remove the need for surgical pockets and wires, reducing complications such as infection and lead failure. Current systems—such as Medtronic’s Micra and Abbott’s Aveir—offer single-chamber and emerging dual-chamber pacing options. These devices demonstrate significantly lower complication rates, excellent battery longevity, and strong real-world performance. Ideal candidates include patients needing single-chamber ventricular pacing, those at high infection risk, or those with limited venous access. Leadless pacing continues to expand as one of the fastest-growing segments in electrophysiology.

Full PDF click HERE